About the Lung GVHD Consortium

The Lung Graft-versus-Host Disease Consortium is a collaboration between Fred Hutchinson Cancer Center, University of Michigan, Stanford University, and MD Anderson Cancer Center, and others, with a goal to understand and combat lung graft-versus-host disease (GVHD) and related lung diseases in patients who have received hematopoietic cell transplant (HCT). These conditions include bronchiolitis obliterans syndrome (BOS), organizing pneumonia and other interstitial lung diseases, early acute lung injury syndromes (such as idiopathic pneumonia syndrome), and infectious pneumonia and complications through the lifespan of the HCT recipient.